Kimberly-Clark Corp.
KMBKimberly-Clark Corp. (KMB) is a leading multinational consumer goods company specializing in the production of personal care, hygiene, and health-related products. The company's offerings include well-known brands such as Kleenex, Huggies, and Scott, serving both retail consumers and commercial businesses worldwide. Founded in 1872, Kimberly-Clark has a long history of innovation in disposable paper products and emphasizes sustainability and social responsibility in its operations.
Dividend History
Investors can expect a dividend payout of $1.26 per share, scheduled to be distributed in 28 days on January 5, 2026
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| January 5, 2026 | $1.26 | 2025-12-05 | 2025-12-05 |
| October 2, 2025 | $1.26 | 2025-09-05 | 2025-09-05 |
| July 2, 2025 | $1.26 | 2025-06-06 | 2025-06-06 |
| April 2, 2025 | $1.26 | 2025-03-07 | 2025-03-07 |
| January 3, 2025 | $1.22 | 2024-12-06 | 2024-12-06 |
Dividends Summary
- Kimberly-Clark Corp. has issued 89 dividend payments over the past 22 years
- The most recent dividend was paid 67 days ago, on October 2, 2025
- The highest dividend payed out to investors during this period was $1.26 per share
- The average dividend paid during this period was $0.84 per share.
Company News
The global cleanroom glove market is projected to grow from $2.51 billion in 2025 to $3.788 billion in 2030, driven by pharmaceutical, biotechnology, and electronics industry demands, with nitrile gloves leading market share and Asia-Pacific region experiencing the fastest growth.
The article discusses undervalued dividend stocks that could perform well during potential economic uncertainty, highlighting that dividend stocks tend to be more stable during recessions.
Kimberly-Clark announced a quarterly dividend of $1.26 per share, payable on January 5, 2026, to stockholders of record as of December 5, 2025. The company has maintained dividend payments for 91 consecutive years and increased dividends for 53 consecutive years.
Kimberly-Clark announced a $49 billion acquisition of Kenvue, causing its stock to drop 14% despite the strategic move to pivot into consumer health and create a $32 billion revenue company with iconic brands.
During periods of heightened volatility, low-beta stocks can provide a valuable layer of defense and a more balanced risk profile. Northrop Grumman, Pfizer, and Kimberly-Clark have recently seen positive earnings estimate revisions, landing them in favorable Zacks Ranks.
